Sponsor

REMD Biotherapeutics, Inc.

Clinical research sponsor

Published trials7

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

7 shown

Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With VolagidemabNCT06272695 · lead sponsor · 2024-02-15

COMPLETED

Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes MellitusNCT03117998 · lead sponsor · 2017-09-19

COMPLETED

Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes MellitusNCT02715193 · lead sponsor · 2016-03-01

COMPLETED

Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of REMD-477 in Subjects With Type 2 Diabetes MellitusNCT02455011 · lead sponsor · 2015-09-01

COMPLETED

Effects of GRA in Patients With Type 1NCT04779645 · collaborator · 2021-07-31

ACTIVE_NOT_RECRUITING

Combination GRA and SGLT-2i Treatment in Type 1 DiabetesNCT04545411 · collaborator · 2021-02-22

COMPLETED

Metabolic Pathways of GRA in Patients With Type 1 DiabetesNCT03919617 · collaborator · 2019-07-01

COMPLETED

Sponsor roles

lead sponsor4

collaborator3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.